Current and historical daily PE Ratio for Parnax Lab Ltd (
) from 2009 to Jun 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Parnax Lab stock (BOM:506128) PE ratio as of Jun 23 2024 is 12.84.
More Details
Parnax Lab Ltd (BOM:506128) PE Ratio (TTM) Chart
Parnax Lab Ltd (BOM:506128) PE Ratio (TTM) Historical Data
View and export this data going back to 2009. Start your Free Trial
Total 1244
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Parnax Lab PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-23 | 12.8 | 2024-04-15 | 15.5 |
| 2024-06-21 | 12.8 | 2024-04-12 | 16.3 |
| 2024-06-20 | 13.1 | 2024-04-10 | 17.1 |
| 2024-06-19 | 13.4 | 2024-04-09 | 18.0 |
| 2024-06-18 | 13.6 | 2024-04-08 | 18.9 |
| 2024-06-14 | 13.9 | 2024-04-05 | 19.4 |
| 2024-06-13 | 13.5 | 2024-04-04 | 17.1 |
| 2024-06-12 | 12.8 | 2024-04-03 | 15.0 |
| 2024-06-11 | 12.2 | 2024-04-02 | 15.2 |
| 2024-06-10 | 11.6 | 2024-04-01 | 15.5 |
| 2024-06-07 | 11.1 | 2024-03-28 | 15.5 |
| 2024-06-06 | 11.2 | 2024-03-27 | 17.6 |
| 2024-06-05 | 11.2 | 2024-03-26 | 17.7 |
| 2024-06-04 | 11.3 | 2024-03-22 | 17.4 |
| 2024-06-03 | 11.9 | 2024-03-21 | 15.9 |
| 2024-05-31 | 11.6 | 2024-03-20 | 14.6 |
| 2024-05-29 | 12.5 | 2024-03-19 | 15.0 |
| 2024-05-28 | 12.2 | 2024-03-18 | 15.7 |
| 2024-05-27 | 12.8 | 2024-03-14 | 15.1 |
| 2024-05-24 | 13.3 | 2024-03-13 | 15.4 |
| 2024-05-23 | 13.1 | 2024-03-12 | 15.2 |
| 2024-05-22 | 13.4 | 2024-03-11 | 14.6 |
| 2024-05-21 | 13.7 | 2024-03-07 | 12.2 |
| 2024-05-17 | 13.6 | 2024-03-06 | 11.4 |
| 2024-05-16 | 13.6 | 2024-03-05 | 11.8 |
| 2024-05-15 | 13.6 | 2024-03-04 | 11.7 |
| 2024-05-14 | 13.7 | 2024-03-01 | 11.6 |
| 2024-05-13 | 13.8 | 2024-02-29 | 11.6 |
| 2024-05-10 | 13.7 | 2024-02-28 | 11.4 |
| 2024-05-09 | 13.8 | 2024-02-27 | 11.5 |
| 2024-05-08 | 13.3 | 2024-02-26 | 11.5 |
| 2024-05-07 | 13.7 | 2024-02-23 | 11.6 |
| 2024-05-06 | 14.0 | 2024-02-22 | 11.7 |
| 2024-05-03 | 14.3 | 2024-02-21 | 11.7 |
| 2024-05-02 | 14.4 | 2024-02-20 | 12.3 |
| 2024-04-30 | 15.0 | 2024-02-19 | 12.7 |
| 2024-04-29 | 15.1 | 2024-02-16 | 12.2 |
| 2024-04-26 | 15.5 | 2024-02-15 | 11.5 |
| 2024-04-25 | 15.4 | 2024-02-14 | 11.1 |
| 2024-04-24 | 15.4 | 2024-02-13 | 11.0 |
| 2024-04-23 | 15.2 | 2024-02-12 | 11.2 |
| 2024-04-22 | 15.5 | 2024-02-09 | 11.4 |
| 2024-04-19 | 16.2 | 2024-02-08 | 11.7 |
| 2024-04-18 | 16.6 | 2024-02-07 | 11.8 |
| 2024-04-16 | 16.2 | 2024-02-06 | 11.9 |
Parnax Lab Ltd (BOM:506128) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Compare
Compare
Traded in other countries / regions
506128.India IPO Date
2009-09-15Description
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers